JPMORGAN CHASE & CO - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 246 filers reported holding KARUNA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.7%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,787,443
-56.8%
34,227
-44.6%
0.00%0.0%
Q2 2023$13,388,969
+40.0%
61,743
+17.3%
0.00%0.0%
Q1 2023$9,564,000
+132825.6%
52,657
+43.8%
0.00%0.0%
Q4 2022$7,195
-99.9%
36,612
+10.0%
0.00%0.0%
Q3 2022$7,489,000
+147.1%
33,297
+38.9%
0.00%
Q2 2022$3,031,000
+18.3%
23,966
+18.5%
0.00%
Q1 2022$2,563,000
+15.8%
20,218
+19.6%
0.00%
Q4 2021$2,213,000
+16.6%
16,901
+8.9%
0.00%
Q3 2021$1,898,000
+16.5%
15,513
+8.6%
0.00%
Q2 2021$1,629,000
+34.2%
14,282
+41.4%
0.00%
Q1 2021$1,214,000
+67.7%
10,101
+41.8%
0.00%
Q4 2020$724,000
+55.7%
7,125
+21.0%
0.00%
Q3 2020$465,000
-20.1%
5,889
+12.6%
0.00%
Q2 2020$582,000
+138.5%
5,228
+54.4%
0.00%
Q1 2020$244,000
+115.9%
3,387
+125.3%
0.00%
Q4 2019$113,000
+253.1%
1,503
-25.2%
0.00%
Q3 2019$32,000
-94.1%
2,009
-92.6%
0.00%
Q2 2019$542,00027,0490.00%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 782,008$142,043,93358.49%
Nan Fung Group Holdings Ltd 225,688$40,993,96827.90%
Sofinnova Investments, Inc. 1,773,124$322,070,24320.60%
Artia Global Partners LP 88,831$16,135,2635.96%
DAFNA Capital Management LLC 78,573$14,272,0004.28%
First Light Asset Management, LLC 243,675$44,261,1273.98%
CATALYST PRIVATE WEALTH, LLC 21,837$3,966,4732.74%
Sands Capital Ventures, LLC 58,895$10,697,6882.64%
ARCH Venture Management, LLC 30,000$5,449,2002.63%
Logos Global Management LP 100,000$18,164,0002.60%
View complete list of KARUNA THERAPEUTICS INC shareholders